Market Value2,369,980,836
Total Holdings50
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
NAMSW / NewAmsterdam Pharma Company N.V. - Equity Warrant
PBYI / Puma Biotechnology, Inc.
ANAB / AnaptysBio, Inc.
CERE / Cerevel Therapeutics Holdings, Inc.
ARVN / Arvinas, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
AGIO / Agios Pharmaceuticals, Inc.
ALLO / Allogene Therapeutics, Inc.
SLNO / Soleno Therapeutics, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
SVRA / Savara Inc.
COGT / Cogent Biosciences, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
VRNA / Verona Pharma plc - Depositary Receipt (Common Stock)
KALV / KalVista Pharmaceuticals, Inc.
HLVX / HilleVax, Inc.
MIRM / Mirum Pharmaceuticals, Inc.
KRYS / Krystal Biotech, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
MGX / Metagenomi, Inc.
TYRA / Tyra Biosciences, Inc.
ETNB / 89bio, Inc.
AVTE / Aerovate Therapeutics, Inc.
RCKT / Rocket Pharmaceuticals, Inc.
ANTX / AN2 Therapeutics, Inc.
CGON / CG Oncology, Inc.
IRON / Disc Medicine, Inc.
GRTSQ / Gritstone bio, Inc.
/ THESEUS PHARMACEUTICALS INC
MDGL / Madrigal Pharmaceuticals, Inc.
APGE / Apogee Therapeutics, Inc.
CRNX / Crinetics Pharmaceuticals, Inc.
MRTX / Mirati Therapeutics, Inc.
NTLA / Intellia Therapeutics, Inc.
ALPN / Alpine Immune Sciences, Inc.
DCPH / Deciphera Pharmaceuticals, Inc.
ADVM / Adverum Biotechnologies, Inc.
BLUE / bluebird bio, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ACAD / ACADIA Pharmaceuticals Inc.
TRVI / Trevi Therapeutics, Inc.
MRUS / Merus N.V.
ORIC / ORIC Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
PEPG / PepGen Inc.
APLT / Applied Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
BBIO / BridgeBio Pharma, Inc.
NAMS / NewAmsterdam Pharma Company N.V.
RVMD / Revolution Medicines, Inc.
MGNX / MacroGenics, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
DYN / Dyne Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
ACRS / Aclaris Therapeutics, Inc.